| Literature DB >> 31244755 |
Corey M Thibeault1, Samuel Thorpe1, Nicolas Canac1, Seth J Wilk1, Robert B Hamilton1.
Abstract
The possibility of sex-related differences in mild traumatic brain injury (mTBI) severity and recovery remains a controversial subject. With some studies showing that female subjects suffer a longer period of symptom recovery, while others have failed to demonstrate differences. In this study, we explored the sex-related effects of mTBI on self-reported symptoms and transcranial Doppler ultrasound (TCD) measured features in an adolescent population. Fifty-eight subjects were assessed-at different points post-injury-after suffering an mTBI. Subjects answered a series of symptom questions before the velocity from the middle cerebral artery was measured. Subjects participated in breath-holding challenges to evaluate cerebrovascular reactivity. The Pulsatility Index (PI), the ratio of the first peaks (P2R), and the Breath-Hold Index (BHI), were computed. Linear mixed effects models were developed to explore the interactions between measured features, sex, and time since injury while accounting for within subject variation. Over the first 10 days post-injury, the female group had significant interactions between sex and time since injury that was not present in the TCD features. This is the first study to compare sex-related differences in self-reported symptoms and TCD measurements in adolescents suffering an mTBI. It illustrates the pitfalls clinicians face when relying on subjective measures alone during diagnosis and tracking of mTBI patients. In addition, it highlights the need for more focused research on sex-related differences in concussion pathophysiology.Entities:
Keywords: CBF autoregulation; blood flow; sex differences; traumatic brain injury; vascular reactivity
Year: 2019 PMID: 31244755 PMCID: PMC6579811 DOI: 10.3389/fneur.2019.00590
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.003
Figure 1Experimental Protocol and TCD Analysis. (A) The individual pulses are extracted before the systolic peak (P1), diastolic trough (D), second peak (P2), and the mean velocity (V) are identified. (B) The CVR protocol consists of a 5-min baseline, left of the first vertical bar, followed by the four breath-holding challenges, between the vertical bars. The low-frequency component of the global signal (solid gray line), is used to compute the baseline mean velocity (V, dashed line) and the largest peak velocity (P) used to calculate the BHI.
Subjects were asked score themselves on the following symptoms based on how they feel now–None (0), Mild (1,2), Moderate (3,4), Severe (5,6).
| Headache |
| Pressure in head |
| Neck pain |
| Nausea or vomiting |
| Dizziness |
| Blurred vision |
| Balance problems |
| Sensitivity to light |
| Sensitivity to noise |
| Vision problems |
| Feeling like in a “fog” |
| “Don't feel right” |
| Difficulty concentrating |
| Difficulty remembering |
| Fatigue or low energy |
| Confusion |
| Drowsiness |
| Trouble falling asleep |
| More emotional |
| Irritability |
| Sadness |
| Nervous or anxious |
Mixed effect model results for symptoms.
| (Intercept) | 2.7 (1.97) | [−1.03, 6.52] | 1.37(215) |
| Sex | 2.91 (3.94) | [−4.58, 10.51] | 0.74(215) |
| 0–1 Days-Post | |||
| 2–3 Days-Post | |||
| 4–5 Days-Post | |||
| 6–7 Days-Post | |||
| 8–9 Days-Post | |||
| 10–11 Days-Post | |||
| 12–13 Days-Post | |||
| Sex:0–1 Days-Post | |||
| Sex:2–3 Days-Post | |||
| Sex:4–5 Days-Post | |||
| Sex:6–7 Days-Post | |||
| Sex:8–9 Days-Post | |||
| Sex:10–11 Days-Post | 11.22 (6.49) | [−1.08, 23.6] | 1.73(228) |
| Sex:12–13 Days-Post | 10.92 (6.95) | [−2.29, 24.09] | 1.57(222) |
The bold rows indicate significant effects or interactions.
Figure 2Features for each sex grouped by days post-injury. (A) Summed symptoms. (B) BHI. (C) PI (D) P2R. Significance values are indicated where a large interaction between sex and days-post was found (**P < 0.01, ***P < 0.001).
Figure 3Self-reported mean symptom scores. (A) Males. (B) Females. The shaded squares without a value are below 1.
Mixed effect model results for BHI.
| (Intercept) | 0.41 (0.02) | [0.37, 0.44] | 23.35(215) |
| Sex | −0.03 (0.03) | [−0.09, 0.04] | −0.73(215) |
| 0–1 Days-Post | −0.02 (0.04) | [−0.09, 0.05] | −0.58(215) |
| 2–3 Days-Post | |||
| 4–5 Days-Post | |||
| 6–7 Days-Post | |||
| 8–9 Days-Post | 0.05 (0.03) | [0, 0.11] | 1.81(231) |
| 10–11 Days-Post | −0.01 (0.03) | [−0.07, 0.05] | −0.32(228) |
| 12–13 Days-Post | 0.01 (0.03) | [−0.05, 0.07] | 0.24(223) |
| Sex:0–1 Days-Post | 0.15 (0.07) | [0.01, 0.29] | 1.98(215) |
| Sex:2–3 Days-Post | 0.05 (0.07) | [−0.1, 0.12] | 0.71(224) |
| Sex:4–5 Days-Post | 0.05 (0.06) | [−0.05, 0.2] | 0.82(222) |
| Sex:6–7 Days-Post | 0 (0.06) | [−0.08, 0.17] | 0.09(231) |
| Sex:8–9 Days-Post | −0.01 (0.06) | [−0.06, 0.16] | −0.23(231) |
| Sex:10–11 Days-Post | 0.01 (0.06) | [−0.1, 0.12] | 0.17(228) |
| Sex:12–13 Days-Post | 0.08 (0.06) | [−0.05, 0.2] | 1.18(223) |
The bold rows indicate significant effects or interactions.
Mixed effect model results for PI.
| (Intercept) | 0.77 (0.02) | [0.73, 0.81] | 35.95(195) |
| Sex | |||
| 0–1 Days-Post | −0.05 (0.04) | [−0.13, 0.02] | −1.33(186) |
| 2–3 Days-Post | 0.03 (0.04) | [−0.04, 0.09] | 0.8(205) |
| 4–5 Days-Post | 0.02 (0.03) | [−0.04, 0.08] | 0.62(211) |
| 6–7 Days-Post | 0.06 (0.03) | [0, 0.12] | 1.99(228) |
| 10–11 Days-Post | 0.03 (0.03) | [-0.04, 0.09] | 0.8(220) |
| 12–13 Days-Post | 0.05 (0.04) | [-0.01, 0.12] | 1.55(205) |
| Sex:0–1 Days-Post | 0.05 (0.08) | [−0.1, 0.2] | 0.68(186) |
| Sex:2–3 Days-Post | 0.11 (0.07) | [−0.09, 0.16] | 1.54(205) |
| Sex:4–5 Days-Post | 0.05 (0.06) | [0, 0.27] | 0.72(211) |
| Sex:6–7 Days-Post | 0.08 (0.06) | [−0.02, 0.24] | 1.23(228) |
| Sex:8–9 Days-Post | 0.01 (0.07) | [−0.08, 0.17] | 0.21(227) |
| Sex:10–11 Days-Post | 0.04 (0.07) | [−0.09, 0.16] | 0.56(220) |
| Sex:12–13 Days-Post | 0.14 (0.07) | [0, 0.27] | 1.96(205) |
The bold rows indicate significant effects or interactions.
Mixed effect model results for P2R.
| (Intercept) | 0.78 (0.01) | [0.75, 0.8] | 62.97(196) |
| Sex | |||
| 0–1 Days-Post | 0.04 (0.02) | [0, 0.08] | 1.69(185) |
| 2–3 Days-Post | 0.01 (0.02) | [−0.02, 0.05] | 0.72(205) |
| 4–5 Days-Post | 0 (0.02) | [−0.03, 0.04] | 0.17(210) |
| 6–7 Days-Post | 0 (0.02) | [−0.03, 0.04] | 0.28(227) |
| 8–9 Days-Post | −0.01 (0.02) | [−0.05, 0.02] | −0.57(226) |
| 10–11 Days-Post | 0 (0.02) | [−0.03, 0.04] | 0.16(220) |
| 12–13 Days-Post | 0 (0.02) | [−0.03, 0.04] | 0.14(204) |
| Sex:0–1 Days-Post | 0.02 (0.04) | [−0.06, 0.11] | 0.42(185) |
| Sex:2–3 Days-Post | 0.01 (0.04) | [−0.06, 0.09] | 0.17(205) |
| Sex:4–5 Days-Post | 0 (0.04) | [−0.1, 0.05] | 0.09(210) |
| Sex:6–7 Days-Post | 0 (0.04) | [-0.07, 0.08] | 0.08(227) |
| Sex:8–9 Days-Post | 0.01 (0.04) | [−0.07, 0.07] | 0.31(226) |
| Sex:10–11 Days-Post | 0.01 (0.04) | [−0.06, 0.09] | 0.39(220) |
| Sex:12–13 Days-Post | −0.03 (0.04) | [−0.1, 0.05] | −0.65(204) |
The bold rows indicate significant effects or interactions.
Figure 4Feature correlations. (A) Male correlations. (B) Female correlations. Correlations that are not significant at the 0.05 level are set to zero.
Feature Correlations for the male and female groups.
| Symptoms | 0.05 ( | −0.12 ( | 0.14 ( |
| BHI | 0.27 ( | −0.18 ( | |
| PI | −0.8 ( | ||
| Symptoms | 0.28 ( | 0.28 ( | −0.11 ( |
| BHI | 0.35 ( | −0.01 ( | |
| PI | −0.67 ( | ||